 |
|
|
| |
Time Course of Hepatic Improvement using the HepQuant® (HQ)-SHUNT Function Test during and after Treatment with Ledipasvir/Sofosbuvir in Liver Transplant Recipients with Allograft Fibrosis or Cirrhosis and Patients with Decompensated Cirrhosis who have not undergone Transplantation
|
| |
| |
Time Course of Hepatic Improvement using the HepQuant® (HQ)-SHUNT Function Test during and after Treatment with Ledipasvir/Sofosbuvir in Liver Transplant Recipients with Allograft Fibrosis or Cirrhosis and Patients with Decompensated Cirrhosis who have not undergone Transplantation
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
James R. Burton Jr.1, Jacqueline G. O'Leary2, Steve Helmke1, Andrea Herman1, Michael Cookson1, Shannon Lauriski1, James F. Trotter2, Jill Denning3, Phillip Pang3, John McHutchison3, Gregory T. Everson1
1University of Colorado Anschutz Medical Campus, Aurora, CO; 2. Baylor University Medical Center, Dallas, TX; 3. Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
